Termination of At-the-Market Subscription Deed

Summary by 6ix AI

Cynata Therapeutics Limited has announced the termination of its At-the-Market Subscription Deed with Acuity Capital, effective from a specified date. The ATM previously provided Cynata with standby equity capital and involved the placement of shares as security. Following termination, the company intends to buy back and cancel the remaining shares held as security without any cash consideration. No termination fee or penalty is applicable to Cynata for this action.

Written by 6ix AI from the company’s filing. How 6ix writes summaries